How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

249 results for

First Aid Travel Kit

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Stephen Colbert sells out to Gwyneth Paltrow and Goop

it was that when I first learned that Gwyneth Paltrow would be a guest on , I was puzzled. The reason, of course, is because over the last two years, through his Covetton House segments, Colbert had turned Gwyneth Paltrow and her lifestyle brand Goop into a running punchline in which he periodically mocked all the New Age nonsense sold by Goop, of all the quackery and pseudoscience marketed primarily to credulous women with, as Mitchell and Webb would put it, more money than sense. Each segment follows (...) the same general pattern. In the first half, Colbert comedically mocks various overpriced nonsensical items sold by Goop, and in the second set he parodies them by introducing Covetton House products patterned on the previously mocked Goop products. Indeed, I find it worth posting a couple of examples, because Colbert’s mockery was so spot on and devastating, For instance, here is where he introduced a fake Covetton House “lifestyle summit”: And here he is in a sketch mocking the “healing stickers

2018 Respectful Insolence

82. In Flight Medical Emergencies: This Doctor Is Now Ready To Heed The Call

cooler and wetter. But we were there the week of the Midwest Polar Vortex so we were satisfied. It’s good to hear someone who truly is both prepared and ready to respond, and willing to do so. As a paramedic I as well as frequent traveler I have seen aid rendered by medical professionals who were probably quite competent in their own specialty but very lost with even ACLS never mind the broader range of medical emergencies and who frankly did more harm than good. The first necessary piece is to have (...) -a good one with which I can hear heart murmurs and lung sounds. Although the FAA-mandated emergency medical kit on board should have both a BP cuff and a stethoscope , I have no confidence they will be either accurate or functional. Sublingual nitroglycerin. The kit on the plane should have these along with 325 mg aspirin tablets, IV atropine, and injectable glucose, epinephrine and lidocaine. An auto-injector. For the stricken passenger who is suffering anaphylaxis from the mixed nuts being served

2019 The Skeptical Cardiologist

83. Skyborn: In-flight Emergency Births on Commercial Airlines. (PubMed)

emergency births are infrequent but not trivial. Commercial airlines are dependent on physicians and other medically trained passengers to help with in-flight deliveries. Despite FAA (U.S. Federal Aviation Authority) and JAA (Joint Aviation Authority) standards, on board medical and First Aid kits are depleted and inadequate for in-flight deliveries.© International Society of Travel Medicine 2019. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail

2019 Journal of Travel Medicine

84. LATITUDE NXT Patient Management System for monitoring cardiac devices at home

indications and settings. LATITUDE NXT Patient Management System for monitoring cardiac devices at home (MIB67) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 23About the technology CE marking CE marking The LATITUDE NXT Patient Management System (including the LATITUDE Communicator and the Communicator accessory and literature kit) is a class III device. Boston Scientific was first awarded a CE mark in March 2012 (...) in the UK have heart failure, commonly caused by coronary artery disease and previous heart attack (NICE guideline on chronic heart failure in adults). Both arrhythmia and heart failure can significantly affect a person's quality of life as well as putting them at risk of sudden cardiac death. The first-line treatment for arrhythmia and heart failure focuses on pharmacological therapy but when this is no longer effective or can no longer be used, one of the following implantable cardiac devices may

2016 National Institute for Health and Clinical Excellence - Advice

85. The cost of the school holidays

provision ? Address barriers to participation caused by the requirement for block-booking, advance payment and face-to-face booking ? Ensure holiday provision is promoted far in advance to support family planning and budgeting for holiday activities ? Address the issue of transport costs to access holiday provision through the provision of holiday travel passes. Adapting content and delivery ? Ensure co-design of services with local people ? Ensure support for parents over holiday periods via provision (...) parents with differing levels of engagement with Glasgow Life holiday provision. ? 2 focus groups were held without any specific demographic in mind: the first with parents of children attending a breastfeeding support group and toddler tales session and another with parents attending a regular support group ? 2 focus groups were held with lone parents due to their prevalence in the city - 40% of families with children in Glasgow are lone parent families – and the greater likelihood of these families

2015 Glasgow Centre for Population Health

86. Recommendation on 36 months isoniazid preventive therapy to adults and adolescents living with HIV in resource-constrained and high TB and HIV-prevalence settings: 2015 update

received non-monetary support from Qiagen (formerly Cellestis) and Oxford Immunotech to perform investigator-initiated research studies, where the kits were in part provided free-of-charge by the two companies. She received travel support from Qiagen for presentation of the data in scientific meetings. She is a co-inventor for a patent application entitled “in vitro process for the quick determination of a patient’s status relating to infection with Mycobacterium tuberculosis” (international patent (...) and writing of the guidelines Alberto Matteelli with input from Haileyesus Getahun. WHO Steering Group Dennis Falzon (Global TB Programme, WHO), Nathan Ford (HIV/AIDS Department, WHO), Haileyesus Getahun (Global TB Programme, WHO), Chris Gilpin (Global TB Programme, WHO), Christian Lienhardt (Global TB Programme, WHO), Knut Lönroth (Global TB Programme, WHO), Alberto Matteelli (Global TB Programme, WHO), Lisa Nelson (HIV/AIDS Department, WHO), Andreas Reis (Knowledge, Ethics and Research Department, WHO

2015 World Health Organisation Guidelines

87. UK National Guideline for the Management of Anogenital Herpes

Objectives The overall aim of the guideline is to prevent morbidity (physical and psychological) associated with genital herpes and ultimately to reduce transmission and prevalence. For some groups, particularly those at high risk of HIV this may have the added benefit of limiting HIV cases. The guideline provides recommendations on the management of adults with anogenital herpes in the UK. Recommendations include diagnostic tests, management of the primary or first episode of anogenital herpes (...) in a representative clinic. The process was overseen by the Clinical Effectiveness Group of BASHH. This is the third revision of the UK national guideline first written in 1999. Definitions Initial episode: First episode with either herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2). Dependent on whether the individual has had prior exposure to the other type, this is further subdivided into: Primary infection: first infection with either HSV-1 or HSV-2 in an individual with no pre-existing antibodies

2015 British Association for Sexual Health and HIV

88. Community management of opioid overdose

and Clinical Toxicologists), Marica Ferri (European Monitoring Centre for Drugs and Drug Addiction), Mauro Guarinieri (the Global Fund to Fight AIDS, Tuberculosis and Malaria), Sharon Stancliff (Harm Reduction Association, USA), Marc Augsburger (The International Association of Forensic Toxicologists), Ruth Birgin (International Network of People who Use Drugs), Hannu Alho (International Society of Addiction Medicine), Simon Lenton (National Drug Research Institute, Australia), Steven Gust (National (...) reviews, presented the findings to the GDG, wrote the first draft of the guidance and assisted with preparation of the final guideline document. Anna Williams and Rebecca McDonald assisted with the preparation of background documentation. WHO staff: Tomas Allen (WHO library) assisted with the development and conduct of the literature search. WHO interns: Agata Boldys (Management of Substance Abuse unit) assisted with the organization of the meeting and the preparation of background documents. Sally

2015 World Health Organisation Guidelines

89. Guidelines on the management of latent tuberculosis infection

of TB related to treatment with bio similar TNF antagonists for one time in 2013. Martina Sester declared that she received non-monetary support from Qiagen and Oxford Immunotech to perform investigator-initiated research studies, where the kits were in part provided free-of-charge by the two companies. She received travel support from Qiagen for presentation of the data in scientific meetings. She is a co-inventor for a patent application entitled “in vitro process for the quick determination (...) Acknowledgements Overall coordination and writing of the guidelines Haileyesus Getahun and Alberto Matteelli helped coordinate the development and drafting of the guidelines, under the overall direction of Mario Raviglione. WHO Steering Group Dennis Falzon (Global TB Programme, WHO), Nathan Ford (HIV/AIDS Department, WHO), Haileyesus Getahun (Global TB Programme, WHO), Chris Gilpin (Global TB Programme, WHO), Christian Lienhardt (Global TB Programme, WHO), Knut Lonnroth (Global TB Programme, WHO), Alberto

2015 World Health Organisation Guidelines

90. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer

to stratify the risk of malignancy in thyroid nodules, and aid decision-making about whether FNA is indicated. Studies consistently report that several US gray scale features in multivariate analyses are associated with thyroid cancer, the majority of which are PTC. These include the presence of microcalci?cations, nodule hypoechogenicity compared with the surrounding thyroid or strap muscles, irregular margins (de?ned as either in?ltrative, microlobulated, or spiculated), and a shape taller than wide

2015 Pediatric Endocrine Society

91. Clinical practice guideline on Systemic Lupus Erythematosus

Clinical practice guideline on Systemic Lupus Erythematosus Clinical Practice Guideline on Systemic Lupus Erythematosus CLINICAL PRACTICE GUIDELINES IN THE SPANISH NHS MINISTRY OF HEALTH, SOCIAL SERVICES AND EQUALITYClinical Practice Guideline on Systemic Lupus Erythematosus MINISTERIO DE SANIDAD, SERVICIOS SOCIALES E IGUALDAD MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD CLINICAL PRACTICE GUIDELINES IN THE SPANISH NHS MINISTRY OF HEALTH, SOCIAL SERVICES AND EQUALITYThis CPG is an aid for decision (...) drugs? 29. What induction treatment in lupus nephritis with renal insufficiency should be administered? 30. What is the immunosuppressive maintenance treatment of proliferative lupus ne- phritis? 31. When and how should a maintenance treatment be suspended? 32. What should be the immunosuppressive therapeutic strategy of first choice for type V lupus nephritis? Haematological manifestations 33. What is the immunosuppressive first-line treatment for severe cytopenia? 34. When should thrombocytopenia

2015 GuiaSalud

92. Chronic Pelvic Pain

with these patients. We therefore plan to make a stepped information structure, in alignment with stepped care protocols. It is the vision of the panel to use new digital information sources like websites and apps to aid this process. Furthermore, the panel wishes to change the guideline according to the template used in all other non-oncology guidelines of the EAU. It has been recognised that structuring a guideline on chronic pain is quite different from structuring one on another subject. Multidisciplinarity (...) is of utmost importance and demands a broad view. For the 2016 version the panel has made plans focussing on two important changes to the guideline. The first one is to rewrite the guideline in such a way that it is centred around pain instead of being organ centred. Chapters are now named after the organ or after the specialist that is consulted by the patient. For the 2016 edition of this guideline, pain will be the centre and every other information will be build around this central theme. The guideline

2015 European Association of Urology

93. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

among survivors of ischemic stroke or TIA. The current average annual rate of future stroke (≈3%–4%) represents a historical low that is the result of important discoveries in prevention science. These include antiplatelet therapy and effective strategies for treatment of hypertension, atrial fibrillation (AF), arterial obstruction, and hyperlipidemia. Since the first of these therapies emerged in 1970, when results of the Veterans Administration Cooperative Study Group trial of hypertension therapy (...) with ischemic stroke or TIA who, after the first several days, have an established BP ≥140 mm Hg systolic or ≥90 mm Hg diastolic ( Class I; Level of Evidence B). Initiation of therapy for patients with BP <140 mm Hg systolic and <90 mm Hg diastolic is of uncertain benefit (Class IIb; Level of Evidence C ). Clarification of parameters for initiating BP therapy Resumption of BP therapy is indicated for previously treated patients with known hypertension for both prevention of recurrent stroke and prevention

Full Text available with Trip Pro

2014 American Heart Association

94. Treatment and recommendations for homeless people with Opioid Use Disorders

practice adaptations. For most of his career, Jay worked in the human services field, first as an emergency medical technician and then as a social worker for the Massachusetts Department of Mental Health, running dual diagnosis programs dealing with mental illness and addiction therapy. He was also an ardent consumer advocate in campaigns promoting patient safety through the use of medications like naloxone (Narcan®), which can help to prevent opioid overdose deaths. He worked with the Boston Health (...) to promote successful treatment of homeless patients with opioid use disorders: a harm reduction/ low-threshold model of care (Denning & Little 2011, Zevin 2011, Stancliff 2012); explicit overdose prevention and management training and naloxone rescue kit access (Wheeler 2012, Walley 2013); integration of primary care with mental health and addiction services provided by a multidisciplinary clinical team (Meinbresse 2013, Goyer 2011); use of creative outreach strategies and unconventional treatment sites

2014 National Health Care for the Homeless Council

95. Framework towards tuberculosis elimination in low-incidence countries

such as HIV/AIDS care and treatment and mental health and substance abuse teams. In some low-incidence countries, indigenous populations (e.g. Aboriginal people or First Nations) and certain ethnic minorities (e.g. Roma) have TB incidence rates that are much higher even than those in the general population in high-incidence countries. This can be due to a combination of higher exposure to TB risk factors, poor access to health care and possibly genetic factors (44). Immigrants from high-incidence (...) realization of the dream. Elimination must still be the aim, but the strategies to reach it must take into account all the obstacles to be overcome (9,14,18,20,22,28,30). 3.2 Special challenges for TB care and prevention in low-incidence countries 3.2.1 Concentration in vulnerable groups As TB incidence falls, TB becomes concentrated in certain vulnerable groups, such as the poor, the homeless, migrants, people living with HIV/AIDS, people with harmful alcohol use, illicit drug users, prisoners and other

2014 World Health Organisation Guidelines

96. Framework for conducting reviews of tuberculosis programmes

version of the document and provided significant input. Malgorzata Grzemska and Salah-Eddine Ottmani compiled the comments provided by the reviewers and finalized the document. Development of this document was funded by the Global Fund To Fight AIDS, Tuberculosis and Malaria under the Contribution Agreement between TGF and WHO in 2012 P.O number. 20043877. Photocredit: WHO/Soleil LabelleFramework for conducting reviews of tuberculosis programmes 1 Contents Abbreviations 2 Foreword 3 1 Introduction (...) of the national tuberculosis programme and to be made available to the reviewers 33 Annex 3 Terms of reference for the TB epidemiological and impact analysis component of a national programme review 36 Annex 4 Checklists for assessing selected areas of tuberculosis activities during a review of a national programme 42 Annex 5 Selected references 442 Abbreviations AFB acid-fast bacilli AIDS acquired immunodeficiency syndrome ART antiretroviral treatment BMU Basic Medical Unit CPT co-trimoxazole preventive

2014 World Health Organisation Guidelines

97. March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

therapy 3. Pharmaceutical equivalence and clinical interchangeability between lamivudine and emtricitabine 4. Use of efavirenz during pregnancy as part of first-line antiretroviral therapy: a public health perspective 5. Optimizing antiretroviral drugs for children: medium- and long-term priorities 6. Changing role of CD4 cell counts in HIV care and treatment 7. Scaling up viral load testing in resource-limited settings Supplementary sections to Chapter 9 – Guidance on operations and service delivery (...) alafenamide fumarate TB tuberculosis TDF tenofovir disoproxil fumarate TEE tenofovir disoproxil fumarate plus emtricitabine plus efavirenz TLE tenofovir disoproxil fumarate plus lamivudine plus efavirenz TNA threose nucleic acid UNAIDS Joint United Nations Programme on HIV/AIDS UNICEF United Nations Children’s Fund XTC 3TC or FTC7 FOREWORD Countries have requested that WHO streamline, in a user- friendly manner, the development and release of HIV-related guidelines and of its technical and programmatic

2014 World Health Organisation HIV Guidelines

98. Abuse and violence - working with our patients in general practice

in this publication is current at the date of first publication and is intended for use as a guide of a general nature only and may or may not be relevant to particular patients or circumstances. This publication is not exhaustive of the subject matter. Persons implementing any recommendations contained in this publication must exercise their own independent skill or judgement or seek appropriate professional advice relevant to their own particular circumstances. Compliance with any recommendations cannot (...) Australia Tel 1800 626 901 Fax 03 9696 7511 www.racgp.org.au ISBN 978-0-86906-384-2 First edition published 1992 Second edition published 1998 Third edition published 2008 Fourth edition published June 2014 © The Royal Australian College of General Practitioners 2014i Abuse and violence Working with our patients in general practice Abuse and violence Working with our patients in general practice (4th edition)iii Abuse and violence Working with our patients in general practice Acknowledgements

2014 Clinical Practice Guidelines Portal

99. Heart Disease and Stroke Statistics?2016 Update

% higher odds with sibling history), stroke (50% higher odds with history in a first-degree relative), atrial fibrillation (AF; 80% higher odds with parental history), heart failure (70% higher odds with parental history), and peripheral arterial disease (80% higher odds with family history). This excess risk reflects genetic, epigenetic, and shared behavioral and environmental risk factors. High Blood Cholesterol and Other Lipids (Chapter 8) 75.7% of children and 46.6% of adults have ideal cholesterol (...) accounted for 30.8% (800 937) of all 2 596 993 deaths, or ≈1 of every 3 deaths in the United States. On the basis of 2013 death rate data, >2200 Americans die of CVD each day, an average of 1 death every 40 seconds. Approximately 155 000 Americans who died of CVD in 2013 were <65 years of age. In 2013, 35% of deaths attributable to CVD occurred before the age of 75 years, which is younger than the current average life expectancy of 78.8 years. For the first time since 1983, more males (402 851) died

2014 American Heart Association

100. ICS Tracheostomy Standards (2014)

of information on the nature of the procedure, proposed benefits, potential hazards and alternatives, ideally written and with visual aids in the first instance, and an example of this is provided in the Appendix. It should be emphasised that like all surgical interventions, this procedure is not undertaken lightly and is not risk-free, however nor is prolonged translaryngeal intubation. Inconsistencies and lack of documentation in consent processes were highlighted in the NCEPOD report. TRACHEOSTOMY CARE (...) travels around with the patient, as suggested in NCEPOD report. The manufactured characteristics of the tube to be considered when selecting a tracheostomy tube for temporary use include: ? Construction Dimensions, internal and outer diameter (ID and OD respectively) proximal and distal length (i.e. length of the tube proximal and distal to angulation), shape and angulation ? Compatibility with percutaneous insertion kit ? Presence and nature of tube cuff ? Presence of inner cannula (dual cannula

2014 Intensive Care Society

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>